These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24998637)
1. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines. Szwed M; Laroche-Clary A; Robert J; Jozwiak Z Chem Biol Interact; 2014 Sep; 220():140-8. PubMed ID: 24998637 [TBL] [Abstract][Full Text] [Related]
2. Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells. Szwed M; Jozwiak Z Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():53-63. PubMed ID: 25308442 [TBL] [Abstract][Full Text] [Related]
3. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells. Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation. Szwed M; Laroche-Clary A; Robert J; Jozwiak Z Cell Oncol (Dordr); 2016 Apr; 39(2):107-18. PubMed ID: 26611752 [TBL] [Abstract][Full Text] [Related]
5. Toxicity of doxorubicin-transferrin conjugate is connected to the modulation of Wnt/β-catenin pathway in human leukemia cells. Szwed M; Kania KD; Jozwiak Z Leuk Res; 2015 Oct; 39(10):1096-102. PubMed ID: 26271413 [TBL] [Abstract][Full Text] [Related]
6. Assessment of pro-apoptotic activity of doxorubicin-transferrin conjugate in cells derived from human solid tumors. Szwed M; Kania KD; Jozwiak Z Int J Biochem Cell Biol; 2016 Jan; 70():57-67. PubMed ID: 26520467 [TBL] [Abstract][Full Text] [Related]
7. Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate. Szwed M; Kania KD; Jozwiak Z Biochimie; 2014 Dec; 107 Pt B():358-66. PubMed ID: 25312849 [TBL] [Abstract][Full Text] [Related]
8. Molecular damage caused by generation of reactive oxygen species in the redox cycle of doxorubicin-transferrin conjugate in human leukemia cell lines. Szwed M; Kania KD; Jozwiak Z Leuk Lymphoma; 2015 May; 56(5):1475-83. PubMed ID: 25166006 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309 [TBL] [Abstract][Full Text] [Related]
10. Transferrin-Bound Doxorubicin Enhances Apoptosis and DNA Damage through the Generation of Pro-Inflammatory Responses in Human Leukemia Cells. Jedrzejczyk M; Wisniewska K; Kania KD; Marczak A; Szwed M Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321722 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells. Marczak A; Denel-Bobrowska M; Rogalska A; Łukawska M; Oszczapowicz I Environ Toxicol Pharmacol; 2015 Jan; 39(1):369-83. PubMed ID: 25561091 [TBL] [Abstract][Full Text] [Related]
13. Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin. Szwed M; Kania KD; Jozwiak Z Cell Oncol (Dordr); 2014 Dec; 37(6):421-8. PubMed ID: 25410120 [TBL] [Abstract][Full Text] [Related]
14. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity. Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247 [TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia. Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351 [TBL] [Abstract][Full Text] [Related]
17. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells. Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918 [TBL] [Abstract][Full Text] [Related]
19. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant. Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766 [TBL] [Abstract][Full Text] [Related]
20. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways. Park SJ; Wu CH; Safa AR Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]